Lanean...
MicroRNA dysregulation and multi-targeted therapy for cancer treatment
We established that loss of miR-15a/16-1 genes on chromosome 13q14 is the most common alteration in Chronic Lymphocytic Leukemia (CLL) and that miR-15/16 are crucial negative regulator of BCL-2, an antiapoptotic gene overexpressed in most CLLs and in many other malignancies. We have also shown that...
Gorde:
| Argitaratua izan da: | Adv Biol Regul |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7056524/ https://ncbi.nlm.nih.gov/pubmed/31640928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbior.2019.100669 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|